Dear Sir,
We took great interest in reading Manek and Coll's paper [1] , who hypothesize the presence of a small Wber neuropathy in primary Raynaud's phenomenon (RP). Indeed, we reached similar results testing 12 patients with secondary RP in systemic sclerosis (SSc) when compared to a group of healthy controls [2] . In these patients, cardiovascular reXexes tested by tilt-test, Valsalva manoeuver, deep breathing and sustained handgrip were normal, but the cold face test was abnormal in almost all patients. By this test, we explored the function of aVerent cutaneous C and A Wbers instead of using the cold pressor test, which is painful and is diYcult to perform in patients with SSc with severe sclerodactyly. In healthy people, a cold stimulus applied to the face during spontaneous breathing evokes bradycardia and peripheral vasoconstriction as measured by increased systolic and diastolic blood pressure [3] . Our patients with SSc with secondary RP showed blunted bradycardic and hypertensive response to cold face test, suggesting that a dysfunction of epidermal small Wbers (C-Wbers) may be involved in SSc.
Manek's observations as well as ours are very preliminary, and the number of patients is too low to deWnitely prove a unique and characteristic small Wber neuropathy in the RP.
However, assuming there is a small Wber neuropathy in both primary and secondary RP, the question arises as to whether the same Wbers are involved or to the same extent in both conditions. There are several observations supporting the idea that this may not be the case.
Autonomic c-Wbers around sweet glands are deep, mostly located between dermis and subcutaneous tissue. Skin biopsy in SSc with secondary RP showed loss of sensory neuropeptidic Wbers sprouting from dermal papillary layer into the epidermis, whereas a similar picture but with less severe loss of Wbers was described in primary RP [4, 5] .
Peripheral neuropathy is intriguingly common evidence of very diVerent diseases such erythromelalgia [6] , connective tissue diseases [2, 5, 7, 8] and RP [1, 2, 4, 5, 9] . It seems unlikely that the same postganglionic neuropathy is involved in all these conditions, unless the small Wber neuropathy is considered as a sign of neuropeptidic dysfunction that may manifest in diVerent pathophysiologic ways thereby leading to a diVerent clinical presentation.
Further studies are needed to clarify this issue, although the number of converging results not due to chance is increasing, possibly opening up new avenues of therapies for these diseases.
